Lyon, France

Maat Pharma


USPTO Granted Patents = 10



Forward Citations = 6

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Carole Schwintner (9 out of 9 patents)

silverMedal Hervé Affagard (8 out of 8 patents)

bronzeMedal Joël Dore (5 out of 6 patents)

4.  Catherine Juste (3 out of 3 patents)

5.  Fernanda Fonseca (3 out of 3 patents)

6.  Christel Maillet (2 out of 2 patents)

7.  Sylvie Rabot (2 out of 2 patents)

8.  Hervé Blottiere (2 out of 3 patents)

9.  Alice Leroux (1 out of 1 patent)

10.  Clémence Mader (1 out of 1 patent)

11.  Patricia Lepage (1 out of 3 patents)

12.  Vincent Thomas (1 out of 9 patents)

13.  Marianne Robin (1 out of 1 patent)

14.  Jean-François Dubuisson (1 out of 40 patents)

15.  Cédric Michenet (1 out of 1 patent)


10 patents:

Company Overview
Maat Pharma is a biotechnology company based in Lyon, France, specializing in the development of innovative therapies for the treatment of liver diseases and related conditions. The company focuses on harnessing the power of microbiome science to create solutions that address unmet medical needs. Maat Pharma's research emphasizes the interplay between gut health and liver function, aiming to improve patient outcomes through advanced therapeutic approaches and a deep understanding of microbiota dynamics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Maat Pharma USPTO Patent Assignee Logo
10 Patents

#35 in Lyon

#1,710 in France

#56,047 in the World

Lyon, FR
Lyon, France
Forward Citations = 6

26 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Maat Pharma. Retrieved from https://idiyas.com/company/maat-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…